Pictet Asset Management Holding Sa Halozyme Therapeutics, Inc. Transaction History
Pictet Asset Management Holding Sa
- $93.5 Billion
- Q2 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 19,188 shares of HALO stock, worth $1.27 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,188
Previous 19,197
0.05%
Holding current value
$1.27 Million
Previous $1.22 Million
18.46%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding HALO
# of Institutions
611Shares Held
127MCall Options Held
408KPut Options Held
388K-
Black Rock Inc. New York, NY17.6MShares$1.17 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$813 Million0.01% of portfolio
-
State Street Corp Boston, MA5.94MShares$394 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.47MShares$230 Million0.03% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.4MShares$225 Million3.92% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $9.24B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...